Literature DB >> 169377

Feline oncornavirus-associated cell membrane antigen. IV. Antibody titers in cats with naturally occurring leukemia, lymphoma, and other diseases.

M Essex, S M Cotter, W D Hardy, P Hess, W Jarrett, O Jarrett, L Mackey, H Laird, L Perryman, R G Olsen, D S Yohn.   

Abstract

Cats with naturally occurring leukemia and lymphoma had low or negative humoral antibody titers to the feline oncornavirus-associated cell membrane antigen (FOCMA). Geographic differences were seen in the relative frequencies of various forms of lymphoproliferative neoplasms. Lymphatic leukemia and thymic lymphoma were most common in Boston, whereas alimentary lymphoma was most frequent in Glasgow. No significant differences were found in geometric mean FOCMA antibody titers for the various forms of leukemia-lymphoma or for feline leukemia virus (FeLV)-positive as compared to FeLV-negative cats. Approximately 70% of 76 Boston cats with nonregenerative anemias were FeLV gs antigen (gsa) positive; this was similar to the percentage with leukemia-lymphoma from the same population that was positive. Fifty-five to 62% of the Boston cats with other infectious diseases, such as peritonitis and septicemia, were gsa positive. We postulate that this is due to a predisposition to infectious diseases by the immunosuppressive action of FeLV. Young cats from the Boston population that developed lymphoma, infectious peritonitis, and certain other diseases were more likely to be FeLV gsa positive than older cats with the same diseases.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169377

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  11 in total

1.  Animal model: feline acute lymphoblastic leukemia and aplastic anemia.

Authors:  S M Cotter; M Essex
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

2.  Target antigens for antibodies and complement at the cell surface of RSV-transformed fibroblasts.

Authors:  M Prat; F Tato; G Tarone; P M Comoglio
Journal:  Immunology       Date:  1980-02       Impact factor: 7.397

3.  Sequence arrangement and biological activity of cloned feline leukemia virus proviruses from a virus-productive human cell line.

Authors:  J I Mullins; J W Casey; M O Nicolson; K B Burck; N Davidson
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

4.  Feline oncornavirus-associated cell-membrane antigen (FOCMA): distinction between FOCMA and the major virion glycoprotein.

Authors:  J R Stephenson; M Essex; S Hino; W D Hardy; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

5.  McDonough feline sarcoma virus: characterization of the molecularly cloned provirus and its feline oncogene (v-fms).

Authors:  L Donner; L A Fedele; C F Garon; S J Anderson; C J Sherr
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

6.  Specificity in the immunosuppression induced by avian reticuloendotheliosis virus.

Authors:  M H Walker; B J Rup; A S Rubin; H R Bose
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

7.  Feline preleukemia: an animal model of human disease.

Authors:  L Maggio; R Hoffman; S M Cotter; N Dainiak; S Mooney; L A Maffei
Journal:  Yale J Biol Med       Date:  1978 Jul-Aug

Review 8.  Diseases associated with spontaneous feline leukemia virus (FeLV) infection in cats.

Authors:  M Reinacher
Journal:  Vet Immunol Immunopathol       Date:  1989-05       Impact factor: 2.046

Review 9.  Clinical aspects of feline immunodeficiency and feline leukemia virus infection.

Authors:  Katrin Hartmann
Journal:  Vet Immunol Immunopathol       Date:  2011-07-21       Impact factor: 2.046

Review 10.  Clinical aspects of feline retroviruses: a review.

Authors:  Katrin Hartmann
Journal:  Viruses       Date:  2012-10-31       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.